💊 Dose, Diabetes & Destiny: The Statin Tradeoff

🚨 Statins & Diabetes: Dose Matters, But So Does Perspective 💊📉   A 2024 CTT Collaboration meta-analysis of 154,664 participants confirms: ✅ Statins modestly increase risk of diabetes (10% with moderate, 36% with high-intensity) 📈 Small upticks in HbA1c and glucose 🧪 But most new cases were already teetering near the threshold   🩺 Bottom line? Cardiovascular benefits far outweigh the diabetes risk. 💡 It's a reminder: precision prevention is about balancing risk, not eliminating it.   📚 Ref: Lancet Diabetes Endocrinol 2024 | DOI: 10.1016/S2213-8587(24)00040-8 #Statins #Diabetes #Cardiology #EvidenceBasedMedicine #Prevention #Lipids #RCT #CTTCollaboration #BalancingBenefits #MedicalResearch